Neo Ivy Capital Management’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-115,428
Closed -$4.17M – 371
2026
Q1
$4.17M Buy
+115,428
New +$4.83M 1.1% 3
2023
Q4
$30K Buy
+408
New +$26.1K 0.07% 219
2022
Q4
– Sell
-1,079
Closed -$57K – 348
2022
Q3
$57K Buy
+1,079
New +$64.5K 0.15% 210
2022
Q2
– Sell
-1,700
Closed -$110K – 415
2022
Q1
$110K Buy
1,700
+1,402
+470% +$95.9K 0.1% 292
2021
Q4
$25K Sell
298
-10,476
-97% -$840K 0.04% 347
2021
Q3
$438K Buy
+10,774
New +$896K 0.5% 65
2020
Q4
– Sell
-2,102
Closed -$83K – 425
2020
Q3
$83K Sell
2,102
-8,672
-80% -$362K 0.08% 306
2020
Q2
$438K Buy
+10,774
New +$424K 0.5% 65
2019
Q2
– Sell
-5
Closed – – 274
2019
Q1
$0 Buy
+5
New +$180 ﹤0.01% 290

Other funds holding BRKR

Neo Ivy Capital Management's BRKR Position: Q2 2026 in Review

Neo Ivy Capital Management sold out of Bruker (BRKR) in Q2 2026, closing a stake of 115,428 shares — an estimated $4.17M sold.

Neo Ivy Capital Management first reported a position in BRKR in Q1 2019 and held it in 9 quarters. The position peaked at $4.17M in Q1 2026. 417 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Neo Ivy Capital Management reported no remaining Bruker position as of Q2 2026 after selling out during the quarter.
  • Neo Ivy Capital Management sold 115,428 Bruker shares in Q2 2026, an estimated $4.17M.
  • Neo Ivy Capital Management first reported a position in Bruker in Q1 2019 and held it in 9 quarters.
  • Neo Ivy Capital Management's Bruker position peaked at $4.17M in Q1 2026.
  • 417 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.